Warning to Dengue Patients: Papaya Juice Can Kill

Have you Googled and Facebooked and read somewhere that Papaya Juice from leaves and seeds can cure dengue?

That is false! Papaya Juice can cause deaths to dengue patients!!!

There is reason to believe that more Dengue deaths occurred this year compared to previous years because more and more people are misled into thinking that Papaya Juice can cure Dengue.

In fact, Papaya Juice can kill dengue patients, and here is the reason why.

Why is Papaya Juice dangerous? Papaya Juice has an enzyme called "Papain."

As you can read in Wikipedia, Papain is an enzyme that breaks down tough meat fibers, and has been used for thousands of years to tenderize meat eaten in its native South America. Meat tenderizers in powder form with Papain as an active component are widely sold.

Did you read that? Papain breaks down meat fibers!

To use ordinary language, Papain "dissolves" meat tissues!

Papaya Juice can dissolve meat like "kobal" or "callus".  So what will happen if you drink it inside your body? Your internal organs and muscle tissues, and your heart muscles will "dissolve" slowly.

Have you ever heard that Papaya Juice is used to tenderize meat in Caldereta or Cockfight Bihag or used to remove hairs from pig's skin?

In short, Papaya Juice when taken internally can "dissolve" or "break down" your internal tissues, organs, veins, arteries, etc!!

Papaya Juice has the enzyme Papain that can cause "rapid heartbeat" and "low blood pressure" and "hard of breathing"

And you could die!!!!

Do not ever us Papaya Juice for internal consumption, or your patient may die.

Here is a warning from US FDA:

US restrictions on marketing[edit]

See also: Proteases (medical and related uses)

On September 23, 2008, the US Food and Drug Administration (FDA) warned companies to stop marketing ophthalmic balanced salt solutions and topical drug products containing papain by November 4, 2008. The FDA said, "Papain-containing drug products in topical form historically have been marketed without approval...".^[12]According to the FDA's statement on the subject, "These unapproved products have put consumers' health in jeopardy, from reports of permanent vision loss with unapproved balanced salt solutions to a serious drop in blood pressure and increased heart rate from the topical papain products," said Janet Woodcock, M.D., director for the Center for Drug Evaluation and Research. In the same FDA announcement, the FDA states the following:

Unapproved topical papain products[edit]

Topical drug ointments containing papain are used to remove dead or contaminated tissue in acute and chronic lesions, such as diabetic ulcers, pressure ulcers, varicose ulcers, and traumatic infected wounds. Trade names for these products include Accuzyme, Allanfil, Allanzyme, Ethezyme, Gladase, Kovia, Panafil, Pap Urea, and Ziox. Other products are marketed under the names of the active ingredients, for instance, papain-urea ointment.

In 2008 the FDA announced its intention to take action against these products because it had received reports of serious adverse events in patients using products containing papain. Reports included hypersensitivity (allergic) reactions that lead to hypotension (low blood pressure) and tachycardia (rapid heart rate). In addition, people allergic to latex can also be allergic to papaya, the source of papain, implying that people with latex sensitivity may be at increased risk of suffering an adverse reaction to a topical papain drug product.

FDA recommended that people with concerns about using topical papain preparations contact their health care provider about discontinuing use.

https://t.co/BLkdDJKtOY